Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Cancer Metastatic × lenvatinib × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Thyroid Carcinoma, Anaplastic 3 Thyroid Cancer, Papillary 3 Neuroendocrine Tumors 3 Adenocarcinoma, Follicular 3 Paraganglioma, Extra-Adrenal 2 Carcinoma, Medullary 2 Thyroid cancer, medullary 1 Thyroid cancer, Hurthle cell 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Thyroid Cancer Metastatic 1 Pheochromocytoma 1 Multiple Endocrine Neoplasia Type 1 1 Differentiated Thyroid Cancer 1 Advanced Thyroid Cancer Patients Who Received Target Therapy 1 Adrenocortical Carcinoma 1

Interventions

lenvatinib 1 Denosumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03732495 2022-03-29

LENVOS

Centre Leon Berard

Phase 2 Unknown

EndocrineHead & Neck

Thyroid Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡